Skip to main content

Cogent Biosciences, Inc.

COGT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001622229

In the last 90 days, Cogent Biosciences, Inc. insiders filed 0 open-market purchases and 1 sale; 322 institutions reported holding it in 13F filings for Q2 2026, worth $7.50B in total; no superinvestor holds it.

13F holders, Q2 2023

Institutional positions in Cogent Biosciences, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
136
−1 vs. Q1 2023
Shares held
88.5M
+13.3M (+17.6%) vs. Q1 2023
Total value
$1.05B
+$237.8M (+29.4%) vs. Q1 2023
New holders
17
59 more added
Sold out
18
39 more reduced

Compare with Q1 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting COGT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2023: 136 institutions
Q1 2021: 69 institutionsQ2 2021: 69 institutionsQ3 2021: 73 institutionsQ4 2021: 82 institutionsQ1 2022: 86 institutionsQ2 2022: 112 institutionsQ3 2022: 134 institutionsQ4 2022: 135 institutionsQ1 2023: 137 institutionsQ2 2023: 136 institutionsQ3 2023: 135 institutionsQ4 2023: 144 institutionsQ1 2024: 146 institutionsQ2 2024: 149 institutionsQ3 2024: 161 institutionsQ4 2024: 177 institutionsQ1 2025: 186 institutionsQ2 2025: 181 institutionsQ3 2025: 195 institutionsQ4 2025: 267 institutionsQ1 2026: 305 institutionsQ2 2026: 322 institutions
Value heldQ2 2023: $1.05B
Q1 2021: $303.3MQ2 2021: $293.7MQ3 2021: $309.6MQ4 2021: $385.2MQ1 2022: $353.6MQ2 2022: $633.3MQ3 2022: $1.10BQ4 2022: $864.1MQ1 2023: $810.4MQ2 2023: $1.05BQ3 2023: $885.8MQ4 2023: $534.0MQ1 2024: $734.3MQ2 2024: $1.02BQ3 2024: $1.32BQ4 2024: $949.5MQ1 2025: $799.6MQ2 2025: $973.2MQ3 2025: $2.29BQ4 2025: $6.18BQ1 2026: $7.17BQ2 2026: $7.50B
Institutions holding COGT and their total value by quarter
QuarterHoldersValue
Q2 2026322$7.50B
Q1 2026305$7.17B
Q4 2025267$6.18B
Q3 2025195$2.29B
Q2 2025181$973.2M
Q1 2025186$799.6M
Q4 2024177$949.5M
Q3 2024161$1.32B
Q2 2024149$1.02B
Q1 2024146$734.3M
Q4 2023144$534.0M
Q3 2023135$885.8M
Q2 2023136$1.05B
Q1 2023137$810.4M
Q4 2022135$864.1M
Q3 2022134$1.10B
Q2 2022112$633.3M
Q1 202286$353.6M
Q4 202182$385.2M
Q3 202173$309.6M
Q2 202169$293.7M
Q1 202169$303.3M

Institutions, Q2 2023

Shares, value and share of portfolio for each institution holding Cogent Biosciences, Inc.; share changes are against Q1 2023.

Institutions holding COGT in Q2 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Boxer Capital, LLC525,000$6.22M0.29%00.0%Unchanged
Ghost Tree Capital, LLC575,000$6.81M2.46%+25,000+4.5%Added
Walleye Capital LLC597,226$7.07M0.12%−189,370−24.1%Reduced
Northern Trust Corp614,330$7.27M0.00%+63,402+11.5%Added
Silverarc Capital Management, LLC620,000$7.34M2.48%+40,736+7.0%Added
Millennium Management LLC620,016$7.34M0.01%+600,774+3,122.2%Added
Assenagon Asset Management S.A.698,271$8.27M0.03%00.0%Unchanged
Candriam Luxembourg S.C.A.772,487$9.15M0.07%−164,654−17.6%Reduced
5AM Venture Management, LLC790,440$9.36M2.33%00.0%Unchanged
Logos Global Management LP800,000$9.47M1.31%−200,000−20.0%Reduced
Baker Bros. Advisors LP979,600$11.6M0.07%+979,600New
Farallon Capital Management, L.L.C.983,452$11.6M0.07%00.0%Unchanged
Cormorant Asset Management, LP1,000,000$11.8M0.67%+300,000+42.9%Added
Dimensional Fund Advisors LP1,117,346$13.2M0.00%+288,384+34.8%Added
Adage Capital Partners GP, L.L.C.1,136,069$13.5M0.03%−250,544−18.1%Reduced
Saturn V Capital Management LLC1,143,368$13.5M7.51%+1,143,368New
Janus Henderson Group PLC1,318,112$15.6M0.01%−344,153−20.7%Reduced
Frazier Life Sciences Management, L.P.1,501,383$17.8M1.06%−657,771−30.5%Reduced
Geode Capital Management, LLC1,510,294$17.9M0.00%+191,986+14.6%Added
Kynam Capital Management, LP1,617,391$19.1M2.93%+1,217,417+304.4%Added
Redmile Group, LLC2,053,333$24.3M0.93%+2,053,333New
Marshall Wace, LLP2,154,087$25.5M0.06%+344,708+19.1%Added
Suvretta Capital Management, LLC2,219,693$26.3M1.41%+400,000+22.0%Added
Vivo Capital, LLC2,244,941$26.6M3.19%+250,000+12.5%Added
Perceptive Advisors LLC2,659,470$31.5M0.91%+377,146+16.5%Added
State Street Corp3,128,103$37.0M0.00%−299,611−8.7%Reduced
Deerfield Management Company, L.P. (Series C)3,366,345$39.9M0.85%+400,000+13.5%Added
Eventide Asset Management, LLC3,440,796$40.7M0.69%+851,018+32.9%Added
Fairmount Funds Management LLC3,558,975$42.1M5.94%+800,000+29.0%Added
Vanguard Group Inc4,436,621$52.5M0.00%+900,362+25.5%Added
VR Adviser, LLC4,684,132$55.5M8.87%−200,845−4.1%Reduced
Point72 Asset Management, L.P.4,685,054$55.5M0.19%+2,448,354+109.5%Added
BlackRock Inc.5,477,662$64.9M0.00%+435,592+8.6%Added
Commodore Capital LP5,566,026$65.9M7.41%+793,605+16.6%Added
TCG Crossover Management, LLC5,631,042$66.7M10.93%+2,000,000+55.1%Added
Ra Capital Management, L.P.6,416,147$76.0M1.43%+416,666+6.9%Added
Affinity Asset Advisors, LLC0$00.00%−143,064−100.0%Sold out
Two Sigma Advisers, LP0$00.00%−98,739−100.0%Sold out
Renaissance Technologies LLC0$00.00%−61,468−100.0%Sold out
Alps Advisors Inc0$00.00%−46,045−100.0%Sold out
Cubist Systematic Strategies, LLC0$00.00%−27,582−100.0%Sold out
Prelude Capital Management, LLC0$00.00%−26,000−100.0%Sold out
Squarepoint Ops LLC0$00.00%−25,958−100.0%Sold out
Jump Financial, LLC0$00.00%−24,400−100.0%Sold out
Balyasny Asset Management LLC0$00.00%−19,974−100.0%Sold out
Two Sigma Investments, LP0$00.00%−16,910−100.0%Sold out
Verition Fund Management LLC0$00.00%−11,920−100.0%Sold out
Simplex Trading, LLC0$00.00%−679−100.0%Sold out
TCI Wealth Advisors, Inc.0$00.00%−431−100.0%Sold out
Crewe Advisors LLC0$00.00%−386−100.0%Sold out
Cutler Group LP0$00.00%−200−100.0%Sold out
Ellevest, Inc.0$00.00%−36−100.0%Sold out
Group One Trading, L.P.0$00.00%−26−100.0%Sold out
Mirabella Financial Services LLP0$00.00%−91,617−100.0%Sold out